Daniel Albert

4.9k total citations · 1 hit paper
94 papers, 3.2k citations indexed

About

Daniel Albert is a scholar working on Rheumatology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel Albert has authored 94 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Rheumatology, 22 papers in Molecular Biology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel Albert's work include Systemic Lupus Erythematosus Research (18 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). Daniel Albert is often cited by papers focused on Systemic Lupus Erythematosus Research (18 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). Daniel Albert collaborates with scholars based in United States, Canada and United Kingdom. Daniel Albert's co-authors include James P. Guevara, Seoyoung C. Kim, Hyon K. Choi, Kyoung Mi Kim, Daniel F. Heitjan, Robert A. Eisenberg, Nortin M. Hadler, James F. Fries, Herbert S. Diamond and Thomas A. Medsger and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Daniel Albert

89 papers receiving 3.0k citations

Hit Papers

Hyperuricemia and coronary heart disease: A systematic re... 2010 2026 2015 2020 2010 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Albert United States 26 1.2k 1.0k 667 539 535 94 3.2k
M L Snaith United Kingdom 29 2.5k 2.1× 778 0.8× 715 1.1× 1.1k 2.1× 295 0.6× 79 3.9k
René‐Marc Flipo France 38 2.8k 2.3× 352 0.3× 559 0.8× 674 1.3× 369 0.7× 212 4.7k
John Highton New Zealand 29 878 0.7× 425 0.4× 321 0.5× 570 1.1× 473 0.9× 106 2.4k
Thomas J A Lehman United States 35 1.6k 1.3× 299 0.3× 419 0.6× 1.1k 2.0× 648 1.2× 106 4.2k
Jozélio Freire de Carvalho Brazil 35 2.0k 1.7× 265 0.3× 571 0.9× 1.0k 1.9× 570 1.1× 275 4.3k
Jun Ying United States 30 1.2k 1.0× 299 0.3× 220 0.3× 458 0.8× 660 1.2× 104 3.0k
Marcos López‐Hoyos Spain 37 937 0.8× 419 0.4× 586 0.9× 1.5k 2.7× 606 1.1× 281 5.1k
Debashish Danda India 29 1.1k 0.9× 548 0.5× 270 0.4× 627 1.2× 418 0.8× 180 3.1k
Laura Andréoli Italy 40 3.1k 2.6× 567 0.5× 504 0.8× 1.6k 2.9× 477 0.9× 195 5.0k
Burkhard F. Leeb Austria 27 3.4k 2.8× 367 0.4× 317 0.5× 1.1k 2.0× 438 0.8× 76 5.2k

Countries citing papers authored by Daniel Albert

Since Specialization
Citations

This map shows the geographic impact of Daniel Albert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Albert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Albert more than expected).

Fields of papers citing papers by Daniel Albert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Albert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Albert. The network helps show where Daniel Albert may publish in the future.

Co-authorship network of co-authors of Daniel Albert

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Albert. A scholar is included among the top collaborators of Daniel Albert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Albert. Daniel Albert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sobrero, Alberto F., Daniel Albert, Elizabeth D. Ferucci, et al.. (2025). Development, Usability, and Validity Evidence of a Rheumatology Telehealth Feedback Form. Arthritis Care & Research. 77(10). 1246–1253.
2.
Demaerschalk, Bart M., Judd E. Hollander, Elizabeth A. Krupinski, et al.. (2022). Quality Frameworks for Virtual Care: Expert Panel Recommendations. SHILAP Revista de lepidopterología. 7(1). 31–44. 28 indexed citations
3.
Albert, Daniel. (2022). Does Cancer Masquerade as Sarcoidosis?. JCR Journal of Clinical Rheumatology. 28(8). 416–419. 2 indexed citations
4.
Albert, Daniel. (2015). Are All Biologics the Same? Optimal Treatment Strategies for Patients With Early Rheumatoid Arthritis. JCR Journal of Clinical Rheumatology. 21(8). 398–404. 10 indexed citations
5.
Kim, Seoyoung C., James P. Guevara, Kyoung Mi Kim, et al.. (2009). Hyperuricemia and risk of stroke: A systematic review and meta‐analysis. Arthritis Care & Research. 61(7). 885–892. 360 indexed citations
6.
Albert, Daniel, Jonathan Dunham, Shaheen Khan, et al.. (2008). Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus. Annals of the Rheumatic Diseases. 67(12). 1724–1731. 172 indexed citations
7.
Albert, Daniel, et al.. (2008). A 32‐year‐old nursing student with hoarseness and dysphagia to solids. Arthritis Care & Research. 59(4). 583–590. 2 indexed citations
8.
Kwan‐Morley, Jennifer & Daniel Albert. (2007). B-cell inhibitors as therapy for rheumatoid arthritis: An update. Current Rheumatology Reports. 9(5). 401–406. 9 indexed citations
9.
10.
Dunkley, Colin, et al.. (2005). A population audit of first clinic attendance with suspected epilepsy. Seizure. 14(8). 606–610. 2 indexed citations
11.
Kim, Seoyoung C., Neil A. Martin, Elizabeth C. Hsia, Reed E. Pyeritz, & Daniel Albert. (2005). Management of Aortic Disease in Marfan Syndrome. Archives of Internal Medicine. 165(7). 749–749. 33 indexed citations
12.
Schears, Gregory J., et al.. (2002). Acute onset of Wegener’s granulomatosis and diffuse alveolar hemorrhage treated successfully by extracorporeal membrane oxygenation. Pediatric Critical Care Medicine. 3(1). 63–66. 17 indexed citations
13.
Kolasinski, Sharon L., James Chung, & Daniel Albert. (2002). What do we know about lupus membranous nephropathy? An analytic review. Arthritis Care & Research. 47(4). 450–455. 17 indexed citations
14.
Albert, Daniel & Edwardine Nodzenski. (1992). Ribonucleotide reductase gene expression during cyclic AMP-induced cell cycle arrest in T lymphocytes. Experimental Cell Research. 203(2). 476–482. 4 indexed citations
15.
Albert, Daniel, et al.. (1990). The dose dependent effect of cyclic AMP on ribonucleotide reductase in mitogen stimulated mononuclear cells. Biochemical and Biophysical Research Communications. 167(2). 383–390. 11 indexed citations
16.
Albert, Daniel & Edwardine Nodzenski. (1989). M2 subunit of ribonucleotide reductase is a target of cyclic AMP‐dependent protein kinase. Journal of Cellular Physiology. 138(1). 129–136. 13 indexed citations
17.
Albert, Daniel, Edwardine Nodzenski, & Ga Won Yim. (1989). Cell Cycle Regulation of Ribonucleotide Reductase M2 Subunit Specific RNA in Wild Type and Mutant S49 Cells. Advances in experimental medicine and biology. 253B. 93–97. 1 indexed citations
18.
Albert, Daniel, et al.. (1988). The diagnosis of polyarteritis nodosa. Arthritis & Rheumatism. 31(9). 1117–1127. 43 indexed citations
19.
Albert, Daniel. (1988). Deoxyadenosine toxicity and cell cycle arrest in hydroxyurea-resistant S49 T-lymphoma cells*1. Experimental Cell Research. 179(2). 417–428. 5 indexed citations
20.
Weisman, Michael H., et al.. (1988). Connective-Tissue Disease Following Breast Augmentation. Plastic & Reconstructive Surgery. 82(4). 626–630. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026